#TxID#IDsky
LightNews LightNews
jschaenmanmd.bsky.social
Just donated - let's go #TxID #IDSky friends ! 🏇 @astinfo.bsky.social
November 10, 2025 at 6:13 PM
asato4kids.bsky.social
#IDSky #PedsID #TxID #PedSky
idsainfo.bsky.social IDSA @idsainfo.bsky.social · 16d
New #IDSAGuidelines! IDSA has released updated evidence-based recommendations on administering age-appropriate Influenza and RSV vaccinations in populations with compromised immunity. https://www.idsociety.org/Seasonal-RTI-Vaccinations-in-Immunocompromised-Patients/
November 4, 2025 at 10:22 PM
germhuntermd.bsky.social
Invasive candidiasis in intensive care medicine: shaping the future of diagnosis and therapy

Martin-Loeches et al, Intensive Care Medicine

link.springer.com/article/10.1... #IDSky #TxID #MedMycoSky
Algorithm for the management of suspected IC with septic shock. *For patients with IC who do not present with septic shock, empiric antifungal therapy should be withheld. In these cases, investigations should focus on obtaining blood cultures and, where relevant, site-directed samples. Biomarkers such as serum BDG may support discontinuation when suspicion decreases but should not be used as a trigger to initiate antifungal therapy. BDG (1 → 3)-β-D-glucan; IC Invasive candidiasis; R Resistance Table 5: Key actions in management of persistent candidemia Table 6 Combination strategies for difficult deep-seated refractory infections. Combination therapy is not routine. Reserve it for the specific scenarios above (endocarditis, CNS involvement, ocular disease, renal candidiasis with obstruction, persistent candidemia or very high fungal burden despite source control, suspected/proven resistance, major PK uncertainty or delayed TDM), begin with a pre-defined 48–72 h reassessment, obtain early susceptibility testing, perform TDM for azoles and consider it for echinocandins in complex PK settings, and de-escalate to the narrowest effective monotherapy as soon as feasible. In summary, avoid routine concurrent Amphotericin B–azole combinations for Candida spp. unless there is a compelling salvage reason; prefer alternative pairs (e.g., echinocandin + azole) if combination therapy is needed. If stepping from an azole to Amphotericin B, be aware of potential carry-over effects; if stepping from Amphotericin B to an azole, keep the overlap brief
October 27, 2025 at 7:21 PM
germhuntermd.bsky.social
New study shows antagonism between olorofim and voriconazole in vitro, suggesting this may be a class effect

academic.oup.com/jac/advance-... #MedMycoSky #TxID #IDSky
October 27, 2025 at 2:58 PM
jschaenmanmd.bsky.social
Attention #IDSky #MedEd #TxID #TID 👀👆@uwidfellowship.bsky.social @harborucla-id.bsky.social @usfidfellowship.bsky.social @umasschanid.bsky.social @templeid.bsky.social @uconn.bsky.social @mgb-id-fellows.bsky.social @yale-id-fellows.bsky.social @lageneral-id.bsky.social @ucsfidfellowship.bsky.social
October 24, 2025 at 5:59 PM
jschaenmanmd.bsky.social
Feeling inspired seeing so many enthusiastic trainees at #IDWeek2025! We have a 2026-27 opening for our 1-year Transplant ID Advanced Training Program at #UCLA, pls reach out with any questions #IDfellow #TxID @idweek.bsky.social #IDSky @ucla-id-fellowship.bsky.social recruit.apo.ucla.edu/JPF10380
Transplant Infectious Diseases Career Development Position 2026-2027
University of California, Los Angeles is hiring. Apply now!
recruit.apo.ucla.edu
October 24, 2025 at 5:52 PM
jschaenmanmd.bsky.social
The great #TxID #IDWeek2025 content continues this morning with 'T cell modifying therapies' at 10:30 today @idweek.bsky.social #IDSky
October 22, 2025 at 12:57 PM
jschaenmanmd.bsky.social
Don't miss this session on 'Respiratory Viruses in Transplant Patients' in the Thomas Murphy ballroom 1:45 today with experts Lara Danziger-Izakov, Deepali Kumar and Roy Chemaly on epidemiology, clinical trials, and approaches to Rx 🦠 💊 💉 #IDWeek2025 #TxID #IDSky @idweek.bsky.social
October 21, 2025 at 3:29 PM
jschaenmanmd.bsky.social
Highway to the donor danger zone? Please join the #TxID crew Tues 8am in B312 for 'Should I Take This Donor?' 🤔 w donor-derived infx experts Stephanie Pouch and Emily Blumberg dropping knowledge on all your donor-related q's ♥️ 🫁 🫘 @aneeshkmehta.bsky.social #IDSky @idweek.bsky.social #IDWeek2025
October 20, 2025 at 6:43 PM
jschaenmanmd.bsky.social
How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB @idweek.bsky.social #IDWeek2025 #TxID #IDSky
October 20, 2025 at 12:33 PM
jschaenmanmd.bsky.social
I will be there! This is definitely a session worth getting up early for ! 🌱 🦠 💊 @idsainfo.bsky.social #idweek2026 #IDSky #TxID
October 19, 2025 at 5:57 PM
jschaenmanmd.bsky.social
Thanks as always for these very helpful links! Great resource for both fellows and current practitioners in #TID #TxID #IDSky
transplantidnet.bsky.social TransplantID.Net - American Society of Transplantation @transplantidnet.bsky.social · Oct 18
For @txidfellows.bsky.social new to 🆔 in #SOT
🤷Where to begin⁉️

"CORE CURRICULUM"▶️ "INTRO SOLID ORGAN TRANSPLANT "📂
👉 intro: StatPearls
👉 drugs: @nejm.org @ast-idcop.bsky.social @cidjournal.bsky.social
👉 THE review @amjtransplant.bsky.social

transplantid.net?core_curricu...
October 19, 2025 at 3:38 PM
josephsassinemd.bsky.social
Also out now in American Journal of Medical Sciences, our review of infectious complications of CAR T and BsAb, led by @ou.edu ID fellow Bradley Dye, a good primer for trainees and faculty alike!

#TxID #IDSky

www.amjmedsci.org/article/S000...
Infectious Complications of Chimeric Antigen Receptor T Cell Therapy and Bispecific Antibodies – A Review
Chimeric antigen receptor (CAR) T cell therapy has shifted the therapeutic landscape of hematological malignancies in the last decade, and bispecific antibodies (BsAb) are an emerging treatment for th...
www.amjmedsci.org
October 18, 2025 at 9:21 AM
josephsassinemd.bsky.social
Out now in @ichejournal.bsky.social , with @ritawilson.bsky.social and others, our report on the blood culture bottle shortage last year affecting the diagnostic yield in febrile neutropenia
@ou.edu
#TxID #IDSky

doi.org/10.1017/ice....
Diagnostic yield of blood cultures in febrile neutropenia—a real-world observational study from an academic medical center during blood culture bottle shortage | Infection Control & Hospital Epide...
Diagnostic yield of blood cultures in febrile neutropenia—a real-world observational study from an academic medical center during blood culture bottle shortage
doi.org
October 10, 2025 at 2:09 PM
germhuntermd.bsky.social
#TxID #IDSky
September 25, 2025 at 12:57 PM
brunorandimd.bsky.social
🚨 Preliminary results! 🚨 Our systematic review & meta-analysis on stopping quinolone prophylaxis pre-engraftment in HSCT — just presented at the XXIV Brazilian Congress of Infectious Diseases.

#HSCT 🧬
#InfectiousDiseases 🌍 #BMT 💉 #IDSky 🌌 #TxID
September 18, 2025 at 6:35 PM
brunorandimd.bsky.social
Outstanding talk by @jobadd.bsky.social at the XXIV Brazilian Congress of Infectious Diseases on invasive fungal infections in solid organ transplantation!
#IDSky #TxID #InfectiousDiseases
September 18, 2025 at 6:34 PM
jschaenmanmd.bsky.social
Reposting this fellowship opportunity for 1 year study of #TxID at @ucla-id-fellowship.bsky.social #IDfellow #IDSky - and we also have a #TxID faculty position available as well !
jschaenmanmd.bsky.social Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · Jul 12
Just posted this #TxID fellowship opportunity on @idsainfo.bsky.social @astinfo.bsky.social @ast-idcop.bsky.social @ishlt.bsky.social - please share with any who might be interested in spending a year in LA ! #IDFellow #IDTwitter #IDSky @ucla-id-fellowship.bsky.social @harborucla-id.bsky.social
jschaenmanmd.bsky.social Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · Jul 3
This just in:Transplant ID Career Development is now open! #TxID #IDSky #IDFellow🔥 @ucla-id-fellowship.bsky.social @domucla.bsky.social This is a 1-yr position- pls reach out with questions 🔬🦠💊@transplantidnet.bsky.social @ast-idcop.bsky.social @txidfellows.bsky.social recruit.apo.ucla.edu/JPF10380
August 15, 2025 at 3:13 PM
priyagargiddoc.bsky.social
Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky

www.ajicjournal.org/article/S019...
The INTERACT study: Infection prevention and surveillance practice in the care of the Australasian cancer and transplant population
Australasian cancer and transplant populations are expanding, with increased infection risk related to prolonged survivorship and broader use of novel immunosuppressants. To optimise care, standardise...
www.ajicjournal.org
August 12, 2025 at 9:06 PM
germhuntermd.bsky.social
Medical cannabis as the source of Cryptococcus neoformans infection

Editor's Choice

Hong Nguyễn's team at @idpittstop.bsky.social

#OpenAccess #MedMycoSky #IDSky #TxID

academic.oup.com/cid/advance-...
Medical cannabis as the source of Cryptococcus neoformans infection
Abstract. Whole genome sequencing demonstrated Cryptococcus neoformans serotype A from cerebrospinal fluid and larynx of a patient receiving therapy for re
academic.oup.com
August 4, 2025 at 5:18 PM
eurofinstransplant.bsky.social
We're honored to welcome Bill Ryan, President of the Transplant Life Foundation and the driving force behind the Transplant Games of America! He’s sharing powerful stories about the transplant community & beyond.

Schedule your interview 🎙 outlook.office365.com/book/Transpl...

#WTC2025 #TxID #IDsky
August 3, 2025 at 10:18 PM
jschaenmanmd.bsky.social
Packed house at talk on #MDR challenging cases at #WTC2025 - clearly a growing concern in #TxID #IDSky discussion of ceftaz avi plus aztreonam v cefidericol for CRE @ast-idcop.bsky.social @txidfellows.bsky.social @astinfo.bsky.social @ttsorg.bsky.social
August 3, 2025 at 3:36 PM
priyagargiddoc.bsky.social
Excited to see what the PROSPER study (point prevalence of infections in cancer & transplant) demonstrates.. @ncicancer.bsky.social 🦠 @bmj.com #TxID #IDSky #EpiSky
Estimating the prevalence of key healthcare-associated and opportunistic infections in Australian transplant and cancer populations: protocol for the PROSPER point prevalence study
Introduction The immunocompromised host (ICH) is at increased risk for a range of opportunistic and healthcare-associated infections (OI/HAIs). With increased use of novel therapeutics and prolonged s...
bmjopen.bmj.com
August 1, 2025 at 9:52 PM
ast-idcop.bsky.social
Congrats to our very own @ealtneu.bsky.social! #TxID #IDSky @astinfo.bsky.social
ast-tyfcop.bsky.social ast-tyfcop.bsky.social @ast-tyfcop.bsky.social · Jul 29
▶️📷 Member Spotlight 📷◀️

Meet Dr. Eric Altneu, Assistant Professor at Temple University!

Get to know more about him 👇👇👇 @ealtneu.bsky.social
July 29, 2025 at 3:16 PM
ast-idcop.bsky.social
Less than one week until #WTC2025! Will we see you there?? #TxID #IDSky
July 28, 2025 at 1:47 PM